Lipo-C is a compounded lipotropic (MIC) injection given in clinics, not an FDA-approved drug with a standardized dose. The pattern below is common clinic context, not a personal protocol, and the evidence that these injections aid weight loss is weak to absent. Formulations vary between clinics.
The short answer
There is no established dose of Lipo-C with B-vitamins, because there is no established product: each compounding pharmacy mixes its own recipe of methionine, inositol, choline, and B-vitamins, and no dose-finding study has ever been run on any of them. What can be described honestly is the administration pattern clinics commonly use — a roughly weekly intramuscular injection given on-site — and why none of the milligram figures attached to it carry evidential weight.
Common clinic pattern
In weight-loss clinics and medical spas, the commonly described pattern is:
- A single intramuscular injection, most often about once a week; some programs schedule more or less frequently.
- Injection volumes typically in the 1–2 mL range, with the amount of each ingredient set by the clinic's compounded formula — numbers from one clinic do not transfer to another.
- Positioning as an adjunct to a supervised diet program, not a standalone treatment.
Because the product is not standardized, no fixed milligram schedule can be stated as authoritative, and none of the circulating figures derive from dose-response research.
Why there is no standard formula
A defensible dose needs a defined product and evidence linking amounts to outcomes. Both are missing here:
- No defined product. "MIC + B12" describes a category, not a formulation. Ratios of methionine, inositol, and choline differ between pharmacies, as do the B-vitamins included.
- No outcome evidence to calibrate against. The nutrient literature the blend borrows from is about dietary requirements — choline's adequate intake is 425–550 mg/day for adults, set to prevent deficiency signs like fatty liver (Zeisel & da Costa, Nutr Rev 2009) — not about injected amounts for weight loss, a use no trial supports.
- The B12 component has a real dosing tradition — but in deficiency medicine, where injection schedules exist for pernicious anemia and malabsorption (O'Leary & Samman, Nutrients 2010). Borrowing deficiency-treatment credibility for wellness dosing in replete customers is the marketing move to see through.
How it is administered
Lipotropic blends are given as intramuscular (sometimes subcutaneous) injections by clinic staff, commonly into the deltoid, thigh, or gluteal muscle. They are clinic-administered — prepared by a compounding pharmacy and injected on-site — rather than a self-injection product. The B-vitamin component (usually B12, which colors the solution red) is what distinguishes this version from the plain MIC blend.
Why oversight matters
Lipo-C is not an FDA-approved therapy with defined indications, and no trial supports a weight-loss benefit at any dose. Within a clinic, at least someone is accountable for the formulation, screening, and sterile administration; reproducing "a weekly MIC shot" outside that setting from generic numbers removes even that layer while keeping all of the uncertainty. Anyone considering these injections is better served asking a clinician the prior question — whether the injection adds anything to the diet program it accompanies — than asking how many milliliters. The research and evidence page walks through why that prior question has no supportive answer yet.